Claudia Martorell, MD

The Research Institute

Disclosure(s): Gilead Sciences: Grant/Research Support; Theratechnologies: Grant/Research Support; ViiV: Grant/Research Support

Poster(s):

• (P-565) A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT